COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits

por Vuk, T., Hećimović, A., Jukić, I., Ravlić, S., Kurtović, T., Rnjak, D., Halassy, B.
Publicado 2021

PB2269: HUMORAL AND T-CELL RESPONSES TO SARS-COV2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA MANAGED IN THE COMMUNITY SETTING

por Holik, H., Krečak, I., Vučinić Ljubičić, I., Cvetko Krajinović, L., Požgain, A., Čabraja, I., Vinković, L., Halassy, B., Mitrović, S., Coha, B.
Publicado 2022

COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?

por Rnjak, D., Ravlić, S., Šola, A.-M., Halassy, B., Šemnički, J., Šuperba, M., Hećimović, A., Kurolt, I.-C., Kurtović, T., Mačak Šafranko, Ž., Polančec, D., Bendelja, K., Mušlin, T., Jukić, I., Vuk, T., Zenić, L., Artuković, M.
Publicado 2021